Ghosal hematodiaphyseal dysplasia syndrome
Alternate names[edit | edit source]
GHDD; Ghosal hematodiaphyseal dysplasia; Ghosal syndrome
Definition[edit | edit source]
Ghosal hematodiaphyseal dysplasia is a rare inherited condition characterized by abnormally thick bones and a shortage of red blood cells (anemia).
Epidemiology[edit | edit source]
Ghosal hematodiaphyseal dysplasia is a rare disorder; only a few cases have been reported in the medical literature. Most affected individuals have been from the Middle East and India.
Cause[edit | edit source]
- Ghosal hematodiaphyseal dysplasia results from mutations in the TBXAS1 gene.
- This gene provides instructions for making an enzyme called thromboxane A synthase 1, which acts as part of a chemical signaling pathway involved in normal blood clotting (hemostasis).
- Based on its role in Ghosal hematodiaphyseal dysplasia, researchers suspect that thromboxane A synthase 1 may also be important for bone remodeling, which is a normal process in which old bone is removed and new bone is created to replace it, and for the production of red blood cells in bone marrow.
Gene mutations[edit | edit source]
- Mutations in the TBXAS1 gene severely reduce the activity of thromboxane A synthase 1.
- Studies suggest that a lack of this enzyme's activity may lead to abnormal bone remodeling and fibrosis of the bone marrow.
- However, the mechanism by which a shortage of thromboxane A synthase 1 activity leads to the particular abnormalities characteristic of Ghosal hematodiaphyseal dysplasia is unclear.
Inheritance[edit | edit source]
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Onset[edit | edit source]
Signs and symptoms of the condition become apparent in early childhood.
Signs and symptoms[edit | edit source]
- In affected individuals, the long bones in the arms and legs are unusually dense and wide.
- The bone changes specifically affect the shafts of the long bones, called diaphyses, and areas near the ends of the bones called metaphyses.
- The bone abnormalities can lead to bowing of the legs and difficulty walking.
- Ghosal hematodiaphyseal dysplasia also causes scarring (fibrosis) of the bone marrow, which is the spongy tissue inside long bones where blood cells are formed.
- The abnormal bone marrow cannot produce enough red blood cells, which leads to anemia.
- Signs and symptoms of anemia that have been reported in people with Ghosal hematodiaphyseal dysplasia include extremely pale skin (pallor) and excessive tiredness (fatigue).
Clinical presentation[edit | edit source]
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.
80%-99% of people have these symptoms
- Abnormal cortical bone morphology
- Abnormal form of the vertebral bodies
- Abnormality of femur morphology(Abnormality of the thighbone)
- Abnormality of immune system physiology
- Abnormality of pelvic girdle bone morphology(Abnormal shape of pelvic girdle bone)
- Abnormality of the metaphysis(Abnormality of the wide portion of a long bone)
- Abnormality of tibia morphology(Abnormality of the shankbone)
- Anemia(Low number of red blood cells or hemoglobin)
- Bowing of the long bones(Bowed long bones)
- Craniofacial hyperostosis(Excessive bone growth of the skull and face)
- Diaphyseal thickening(Thickening of shaft or central part of long bones)
5%-29% of people have these symptoms
- Hyperostosis cranialis interna(Excessive growth of inner surface of the skull bones)
- Leukopenia(Decreased blood leukocyte number)
- Neurological speech impairment(Speech disorder)
- Splenomegaly(Increased spleen size)
Diagnosis[edit | edit source]
The diagnosis was established by clinical presentation and X-ray bone survey. [1]
Treatment[edit | edit source]
Treatment with corticosteroids, leading to considerable improvement in anemia and bony changes, negating the need for blood transfusions. [2].
References[edit | edit source]
- ↑ Shakiba M, Shamsian S, Malekzadeh H, Yasaei M. Ghosal Hematodiaphyseal Dysplasia: A Case Report. Int J Hematol Oncol Stem Cell Res. 2020 Apr 1;14(2):127-129. PMID: 32461797; PMCID: PMC7231795.
- ↑ Arora R, Aggarwal S, Deme S. Ghosal hematodiaphyseal dysplasia-a concise review including an illustrative patient. Skeletal Radiol. 2015 Mar;44(3):447-50. doi: 10.1007/s00256-014-1989-0. Epub 2014 Aug 30. PMID: 25172219.
NIH genetic and rare disease info[edit source]
Ghosal hematodiaphyseal dysplasia syndrome is a rare disease.
Ghosal hematodiaphyseal dysplasia syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD